Wolverine Asset Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,379
Closed -$1.25M 1769
2024
Q3
$1.25M Buy
5,379
+1,634
+44% +$336K 0.01% 625
2024
Q2
$756K Buy
3,745
+800
+27% +$144K 0.01% 749
2024
Q1
$505K Sell
2,945
-2,218
-43% -$414K 0.01% 807
2023
Q4
$1.12M Buy
5,163
+4,763
+1,191% +$817K 0.01% 675
2023
Q3
$63.8K Buy
+400
New +$89.6K ﹤0.01% 1199
2021
Q1
Sell
-547
Closed -$139K 2212
2020
Q4
$139K Buy
547
+232
+74% +$57.6K ﹤0.01% 1147
2020
Q3
$74K Buy
315
+305
+3,050% +$64.2K ﹤0.01% 1189
2020
Q2
$1K Sell
10
-678
-99% -$130K ﹤0.01% 1496
2020
Q1
$113K Buy
+688
New +$126K ﹤0.01% 1019
2019
Q4
Sell
-57,000
Closed -$9.4M 1494
2019
Q3
$9.4M Buy
57,000
+31,202
+121% +$4.39M 0.12% 147
2019
Q2
$3.08M Buy
+25,798
New +$2.64M 0.04% 336
2018
Q3
Sell
-2,290
Closed -$196K 1615
2018
Q2
$196K Sell
2,290
-200
-8% -$17.9K ﹤0.01% 1109
2018
Q1
$215K Buy
+2,490
New +$193K ﹤0.01% 1137
2015
Q3
Sell
-2,900
Closed -$88K 1950
2015
Q2
$89K Buy
+2,900
New +$85.5K ﹤0.01% 1160
2013
Q3
Sell
-6,538
Closed -$205K 2834
2013
Q2
$205K Buy
+6,538
New +$185K 0.01% 1117

Other funds holding PODD

Wolverine Asset Management's PODD Position: Q4 2024 in Review

Wolverine Asset Management sold out of Insulet (PODD) in Q4 2024, closing a stake of 5,379 shares — an estimated $1.25M sold.

Wolverine Asset Management first reported a position in PODD in Q2 2013 and held it in 15 quarters. The position peaked at $9.4M in Q3 2019. 683 funds tracked by Wall St. Rank hold PODD as of Q4 2024.

  • Wolverine Asset Management reported no remaining Insulet position as of Q4 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 5,379 Insulet shares in Q4 2024, an estimated $1.25M.
  • Wolverine Asset Management first reported a position in Insulet in Q2 2013 and held it in 15 quarters.
  • Wolverine Asset Management's Insulet position peaked at $9.4M in Q3 2019.
  • 683 funds tracked by Wall St. Rank held Insulet as of Q4 2024.

Based on Wolverine Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.